Inovio Pharmaceuticals
INO
#9821
Rank
HK$0.62 B
Marketcap
HK$7.61
Share price
-4.89%
Change (1 day)
-35.82%
Change (1 year)

Inovio Pharmaceuticals (INO) - Total liabilities

Total liabilities on the balance sheet as of March 2026 : HK$0.34 Billion

According to Inovio Pharmaceuticals's latest financial reports the company's total liabilities are HK$0.34 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Inovio Pharmaceuticals - Total liabilities on balance sheet (from 2001 to 2026)

Total liabilities by year

Year Total liabilities Change
2025-12-31HK$0.39 B12.6%
2024-12-31HK$0.34 B-17.12%
2023-12-31HK$0.41 B-57.53%
2022-12-31HK$0.98 B31.32%
2021-12-31HK$0.75 B23.15%
2020-12-31HK$0.60 B-43.51%
2019-12-31HK$1.07 B212.58%
2018-12-31HK$0.34 B-1.27%
2017-12-31HK$0.34 B-10.41%
2016-12-31HK$0.39 B32.83%
2015-12-31HK$0.29 B87.08%
2014-12-31HK$0.15 B-42.76%
2013-12-31HK$0.27 B244.3%
2012-12-31HK$79.69 M-22.53%
2011-12-31HK$0.10 B47.43%
2010-12-31HK$69.77 M-53.72%
2009-12-31HK$0.15 B-1.87%
2008-12-31HK$0.15 B125.44%
2007-12-31HK$68.14 M-29.61%
2006-12-31HK$96.81 M126.69%
2005-12-31HK$42.7 M1.73%
2004-12-31HK$41.97 M358.45%
2003-12-31HK$9.15 M-30.68%
2002-12-31HK$13.2 M1.4%
2001-12-31HK$13.02 M
2001-03-31HK$12.44 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Johnson & Johnson
JNJ
HK$938.67 B 273,773.07%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
HK$624.21 B 182,023.71%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
HK$919.12 B 268,067.19%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
HK$257.56 B 75,048.77%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
HK$648.90 B 189,228.13%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
HK$471.94 B 137,597.70%๐Ÿ‡ฌ๐Ÿ‡ง UK
Arrowhead Pharmaceuticals
ARWR
HK$13.09 B 3,719.21%๐Ÿ‡บ๐Ÿ‡ธ USA